SiNW Biosensor Label-Free Anticancer Drug Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current electrochemical biosensors face challenges in reliability and commerciality due to complexity of chemical modifications and non-specific binding, limiting their effectiveness in detecting cancer cells' responses to anticancer drugs without the need for label-free interactions.
Innovation Solution
A label-free electrochemical biosensor using integrated silicon nanowires (SiNWs) electrodes, which include a working, counter, and reference electrode, configured to measure electrical responses from cancer cells, allowing for precise detection of anticancer drug effects by monitoring ionic state changes without the need for labels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If chemical modifications are used to enable biosensing, then sensing capability is improved, but device complexity and reliability deteriorate due to complexity of chemical modifications and non-specific binding
Solution Approach 1:
The patent extracts and eliminates the need for chemical modifications and labels from the biosensing system. By using label-free electrochemical detection, the complex chemical modification steps and associated non-specific binding problems are completely removed, while sensing capability is maintained through direct detection of cellular electrochemical properties
Solution Approach 2:
The patent replaces chemical interaction mechanisms with electrochemical detection mechanisms. Instead of relying on chemical modifications and label binding, the system uses electrochemical sensors to directly detect changes in cellular ion transport and membrane potential, substituting chemical complexity with electrical measurement simplicity
2Measurement precision
If chemical modifications and labels are used, then detection capability is improved, but reliability deteriorates due to non-specific binding
Solution Approach 1:
The patent removes labels and chemical modification requirements from the detection system. By implementing label-free electrochemical detection, it eliminates the source of non-specific binding while maintaining detection capability through direct measurement of cellular electrochemical activity
Solution Approach 2:
The cellular electrochemical properties serve as the detection target themselves without requiring external labels. The cells' own ion transport and membrane potential changes provide the detection signal, making the system self-sufficient and eliminating reliability issues associated with label binding
3Measurement precision
If conventional biosensors are used, then detection function is achieved, but productivity deteriorates due to slow detection speed
Solution Approach 1:
The patent replaces slow chemical reaction-based detection with fast electrochemical measurement. By detecting electrical signals from cellular ion transport in real-time, the system achieves rapid detection without the time delays associated with chemical modification and label binding processes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The SiNW-based biosensor provides a high-precision, fast detection method for monitoring cancer cells' electrochemical state variations during treatments, enabling effective monitoring of anticancer drug effects through measurable changes in anodic/cathodic current peaks.
Implementation Method 1
Such binding must induce changing in electrochemical signal of redox reporter. Moreover, if the oxidative/reductive electrochemical responses of the analyte were unique for different biological transformations
Data Source
AI summary
A biosensor for measuring an electrical response from a biological sample. The biosensor includes a substrate, a passivation layer grown on a surface of the substrate, a patterned catalyst layer deposited on the passivation layer, and three electrodes grown on the patterned catalyst layer. The three electrodes include a working electrode, a counter electrode, and a reference electrode. The working electrode includes a first array of electrically conductive biocompatible nanostructures that is configured to be an attachment site for the biological sample. The counter electrode includes a second array of electrically conductive biocompatible nanostructures that is configured to acquire the electrical response from the working electrode. The reference electrode includes a third array of electrically conductive biocompatible nanostructures that is configured to adjust a specific voltage around the working and the counter electrodes.